~~<i id='CB61F9F233'><strike id='CB61F9F233'><tt id='CB61F9F233'><pre id='CB61F9F233'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

hotspot

author：fashion 2025-09-02 05:54:48 - browse：32981

translucent 3D DNA helix with blue and purple background — Adobe

Verve Therapeutics said Monday that it had received clearance from the Food and Drug Administration to conduct a clinical trial in the U.S. of its experimental, gene-editing treatment for a common form of heart disease.

The FDA’s action removes a clinical hold on Verve’s CRISPR-based therapy, called VERVE-101, that was placed on it last November. Verve now intends to recruit participants from U.S. sites into a Phase 1 study that’s been underway since last year in New Zealand and the United Kingdom.

“We’re thrilled to get this clearance for VERVE-101,” said Verve CEO Sek Kathiresan. “Our study is called HEART-1 and our plan now is to activate U.S. sites.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： STAT Virtual Event: ASCO Recap, Live!

hotspot

leisure time

hotspot

explore

hotspot

focus

Howdocancerdrugswork?Whatmakesbiotechstocksgoup?Andwhyareventurecapitalistssooptimistic?Wecoverallth

WSS

My daughter's legacy lives on through her writing, phage therapy

Curing rare childhood diseases will falter unless Congress steps up

STAT Virtual Event: ASCO Recap, Live!

5 takeaways from STAT's examination of Zynex Medical

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

5 takeaways from STAT's examination of Zynex Medical

knowledge

hotspot

hotspot

How one medical school became remarkably diverse

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Hepatitis C has a cure — but many Americans still lack access to it

Cigna wins case to block Amy Bricker's move to CVS

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Bill would allow buprenorphine prescription for addiction via telehealth

Activists slam private health insurers over coverage restrictions

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Wildfire smoke exposes gaps in outdoor worker protections

Bill would allow buprenorphine prescription for addiction via telehealth

leisure time

Travis Kelce and the trap of celebrity vaccine endorsements

Cigna wins case to block Amy Bricker's move to CVS

All of Us, NIH's precision medicine initiative, gets a big boost

The health care issue Democrats can’t solve: hospital reform

California wildfire smoke linked to 52,000 early deaths, study says

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

hotspot

explore

hotspot

focus